Hemorrhagic cystitis in patients treated with cabazitaxel: a radiation recall syndrome?

Ann Oncol. 2014 Jun;25(6):1248-9. doi: 10.1093/annonc/mdu132. Epub 2014 Apr 1.

Authors

T Grellety¹, N Houédé², J L Hoepffner³, J Rivière³, C Mérino⁴, V Lieutenant¹, M Gross-Goupil¹, P Richaud⁵, C Dupin⁵, P Sargos⁵, G Roubaud⁶

Affiliations

¹ Department of Medical Oncology, Institut Bergonié, Bordeaux.
² Department of Medical Oncology, Institut Bergonié, Bordeaux Department of Medical Oncology, CHU Caremeau, Nîmes.
³ Urology Department, Saint Augustin Clinic, Bordeaux.
⁴ Department of Pathology CAP, Bordeaux.
⁵ Department of Radiotherapy, Institut Bergonié, Bordeaux, France.
⁶ Department of Medical Oncology, Institut Bergonié, Bordeaux g.roubaud@bordeaux.unicancer.fr.

PMID: 24692580
DOI: 10.1093/annonc/mdu132

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Antineoplastic Agents / adverse effects*
Cystitis / etiology*
Hematuria / etiology*
Humans
Male
Middle Aged
Prostatic Neoplasms / therapy*
Radiation Injuries / complications
Radiotherapy / adverse effects*
Taxoids / adverse effects*

Substances

Antineoplastic Agents
Taxoids
cabazitaxel